company

BIOBANK AS

2317 HAMAR

Return on Equity
3,44 %
Current Ratio
4,84
Debt-to-Equity Ratio
0,37
Key figures (NOK)2022
Revenue14 537 000
Net Income300 000
Total Assets14 479 000
Total Equity8 721 000
Income (NOK)2022
Revenue14 537 000
Expenditure14 203 000
Operating Profit334 000
Financial Income68 000
Financial Costs31 000
Financial Balance37 000
Earnings Before Tax371 000
Tax72 000
Net Income300 000
Balance (NOK)2022
Total Fixed Assets2 396 000
Total Current Assets12 082 000
Total Assets14 479 000
Total Retained Equity8 421 000
Total Equity8 721 000
Total Long-Term Debt3 262 000
Total Current Debt2 496 000
Total Equity and Debt14 479 000
Cash flow (NOK)2022
Sales Income14 537 000
Other Income0
Revenue14 537 000
Cost of Goods Sold2 773 000
Salary Costs6 295 000
Depreciation690 000
Impairment0
Expenditure14 203 000
Operating Profit334 000
Financial Income68 000
Financial Costs31 000
Financial Balance37 000
Dividends0
Net Income300 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets1 007 000
Real Eastate52 000
Machinery and Plant Facilities0
Fixtures338 000
Total Tangible Assets390 000
Total Fiancial Fixed Assets1 000 000
Total Fixed Assets2 396 000
Stock0
Total Investments0
Cash, Bank7 827 000
Total Current Assets12 082 000
Total Assets14 479 000
Total Equity8 721 000
Short-Term Group Debt0
Total Long-Term Debt3 262 000
Creditors743 000
Unpaid Taxes948 000
Dividends0
Other Current Debt607 000
Total Current Debt2 496 000
Total Equity and Debt14 479 000
Financial indicators2022
Return on Equity3,44 %
Debt-to-Equity Ratio0,37
Operating Profit Margin2,3 %
Current Ratio4,84
Quick Ratio4,84
Equity Ratio0,6
Gross Profit Margin80,92 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English